Literature DB >> 25164552

Suppression of aldosterone and progesterone in preeclampsia.

Mohammad N Uddin1,2, Darijana Horvat1, Richard O Jones1, Madhava R Beeram2, David C Zawieja3, Lena Perger4, David C C Sprague5, Thomas J Kuehl1,2.   

Abstract

OBJECTIVE: Preeclampsia (preE) is a hypertensive disorder seen in 3-10% of human pregnancies and is diagnosed by de novo onset of hypertension and proteinuria. Several research groups provided evidence for reduced aldosterone (Aldo) and progesterone (Prog) availability in preE. The aim of this study was to determine the levels of Aldo and Prog in preE.
METHODS: Normal pregnant (NP; n = 39) and preE (n = 30) patients were recruited to have their blood drawn between 21 and 40 weeks of pregnancy. Two groups of rats were used in this study: NP rats (n = 10) and preE rats (n = 10), which were given weekly injections of desoxycorticosterone acetate and 0.9% saline to drink. Aldo and Prog levels were assayed in plasma and urine samples by ELISA kits.
RESULTS: In preE patients, the mean Aldo and Prog levels were suppressed (p < 0.05) compared to NP patients. NP patients exhibited a trend of increased levels of Aldo with an increase in gestational age; however, preE patients had the opposite trend. Both normal and preE patients exhibited a trend of increased levels of Prog with an increase in gestational age. The plasma and urinary Aldo and Prog levels were lower (p < 0.05) in preE rats compared to NP rats.
CONCLUSIONS: We have demonstrated using a rat model and patients that both Aldo and Prog are suppressed in preE and thus may be used as biomarkers for preE.

Entities:  

Keywords:  Aldosterone; preeclampsia; pregnancy; progesterone

Year:  2014        PMID: 25164552     DOI: 10.3109/14767058.2014.951627

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

Review 1.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

2.  Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF.

Authors:  Stavros Giaglis; Maria Stoikou; Chanchal Sur Chowdhury; Guenther Schaefer; Franco Grimolizzi; Simona W Rossi; Irene Mathilde Hoesli; Olav Lapaire; Paul Hasler; Sinuhe Hahn
Journal:  Front Immunol       Date:  2016-12-05       Impact factor: 7.561

3.  Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case-control study.

Authors:  Lise H Nielsen; Camilla Kronborg; Erik Vittinghus; Gitte Kitlen; Boye L Jensen; Ulla B Knudsen; Per G Ovesen
Journal:  BMJ Open       Date:  2019-06-21       Impact factor: 2.692

4.  Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia.

Authors:  Lesia O Kurlak; Fiona Broughton Pipkin; Markus G Mohaupt; Hiten D Mistry
Journal:  Clin Kidney J       Date:  2019-03-25

Review 5.  11β-Hydroxysteroid Dehydrogenase 2 in Preeclampsia.

Authors:  Katarzyna Kosicka; Anna Siemiątkowska; Franciszek K Główka
Journal:  Int J Endocrinol       Date:  2016-04-21       Impact factor: 3.257

Review 6.  Sex Steroids Modulate Uterine-Placental Vasculature: Implications for Obstetrics and Neonatal Outcomes.

Authors:  Manuel Maliqueo; Bárbara Echiburú; Nicolás Crisosto
Journal:  Front Physiol       Date:  2016-04-26       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.